Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Shanghai - Delayed Quote CNY

Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS)

Compare
21.33
-2.37
(-10.00%)
As of 11:22:29 AM GMT+8. Market Open.
Loading Chart for 600645.SS
  • Previous Close 23.70
  • Open 22.05
  • Bid --
  • Ask 21.33 x --
  • Day's Range 21.33 - 22.93
  • 52 Week Range 15.05 - 25.40
  • Volume 18,913,100
  • Avg. Volume 11,173,398
  • Market Cap (intraday) 9.981B
  • Beta (5Y Monthly) 0.53
  • PE Ratio (TTM) 88.88
  • EPS (TTM) 0.24
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date Aug 10, 2001
  • 1y Target Est --

Vcanbio Cell & Gene Engineering Corp., Ltd, together with its subsidiaries, primarily engages in the preparation and storage of cell detection tests in the People's Republic of China. The company provides cell test preparation and storage services for umbilical cord blood hematopoietic stem cells, umbilical cord mesenchymal stem cells, placental sub totipotent stem cells, immune cells, adipose stem cells, and dental stem cells. It also provides genetic testing services related to non-invasive prenatal genetic testing during pregnancy, genetic testing for drug safety guidance, disease genetic testing, and disease susceptibility testing for children and adults; and in vitro diagnostic raw materials, such as monoclonal antibodies and polyclonal antibody products. In addition, the company is involved in the research, development, production, and sales of biological genes, proteins, antibodies, pharmaceutical intermediates, and synthetic agents; and in vitro diagnostic reagents and medical devices. The company was founded in 1992 and is based in Tianjin, the People's Republic of China.

www.vcanbio.com

2,209

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 600645.SS

View More

Performance Overview: 600645.SS

Trailing total returns as of 4/7/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

600645.SS
10.52%
SSE Composite Index (000001.SS)
6.60%

1-Year Return

600645.SS
31.34%
SSE Composite Index (000001.SS)
2.00%

3-Year Return

600645.SS
7.66%
SSE Composite Index (000001.SS)
3.27%

5-Year Return

600645.SS
14.06%
SSE Composite Index (000001.SS)
10.99%

Compare To: 600645.SS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 600645.SS

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    11.09B

  • Enterprise Value

    9.76B

  • Trailing P/E

    98.75

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    6.74

  • Price/Book (mrq)

    3.07

  • Enterprise Value/Revenue

    6.13

  • Enterprise Value/EBITDA

    71.71

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    6.74%

  • Return on Assets (ttm)

    1.63%

  • Return on Equity (ttm)

    2.71%

  • Revenue (ttm)

    1.59B

  • Net Income Avi to Common (ttm)

    107.45M

  • Diluted EPS (ttm)

    0.24

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.44B

  • Total Debt/Equity (mrq)

    3.37%

  • Levered Free Cash Flow (ttm)

    156.94M

Research Analysis: 600645.SS

View More

Company Insights: 600645.SS

Research Reports: 600645.SS

View More

People Also Watch